Recursion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Recursion (NASDAQ:RXRX), a clinical stage TechBio company, has announced its participation in two upcoming investor conferences in September 2025. The company will present at the Citi 2025 BioPharma Back to School Conference on September 3 and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8. Investors can access the webcasts through Recursion's investor relations website at ir.recursion.com.

News Market Reaction – RXRX

+1.24%

+1.24% Session close to close

In the Aug 27 session, RXRX gained 1.24%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Salt Lake City, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:

• Citi 2025 BioPharma Back to School Conference — Wednesday, September 3, 2025
• Morgan Stanley 23rd Annual Global Healthcare Conference — Monday, September 8, 2025

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Investor Contact
investor@recursion.com

Media Contact
media@recursion.com

FAQ

When is Recursion (RXRX) presenting at the Citi BioPharma Conference 2025?

Recursion will present at the Citi BioPharma Back to School Conference on Wednesday, September 3, 2025.

When is Recursion's presentation at the Morgan Stanley Healthcare Conference 2025?

Recursion will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8, 2025.

Where can I watch Recursion's (RXRX) investor conference webcasts?

Recursion's conference webcasts can be accessed through the events section of their investor relations website at ir.recursion.com.

What type of company is Recursion (RXRX)?

Recursion is a clinical stage TechBio company focused on decoding biology to radically improve lives.